2Angus D C,Linde-Zwirble W T,Lidicker J,et al. Epidemiology of severe sepsis in the United States:analysis of incidence, outcome ,and associated costs of care [J]. Crit Care Med, 2001, 29(7) : 1303-1310.
3Angus D C,Wax R S. Epidemiology of sepsis:an update[J]. Crit Care Med,2001,29(7 Suppl):S109-116.
4Levy M M, Fink M P, Marshall J C, et al. 2001 SCCM/ ESICM/ACCP/ATS/SIS international sepsis definitions conference[J]. Crit Care Med,2003,31(4) :1250-1256
5Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis[J]. Crit Care Med,1999,27(3):639-660.
6Vincent J L. Hemodynamic support in septic shock [J]. Intensive Care Med,2001,27 Suppl 1 :S80-92.
7Martin C, Papazian L, Perrin G, et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock[J]? Chest, 1993,103(6) : 1826-1831.
8Meier-Hellmann A, Sakka S, Reinhart K, et al. Dopamine in septic patients[J]. Crit Care Med,2000,28(7):2674-2675.
9Reinhart K, Sakka S G, Meier-Hellmann A. Haemodynamic management of a patient with septic shock [J]. Eur J Anaesthesiol,2000,17(1) : 6-17.
10Beale R J,Hollenberg S M,Vincent J L ,et al. Vasopressor and inotropic support in septic shock: an evidence-based review [J]. Crit Care Med,2004,32(11 Suppl) :S455-465.
